Overview
The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.
Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
Need approval in order to attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.Check out our 2019 Program!
Why Attend?
Featured
Who should attend?
Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:
- Clinical data management/eClinical
- Comparative effectiveness/health technology assessment
- Clinical safety/pharmacovigilance
- Clinical research
- Document management/eSubmissions
- Medical communications
- Outsourcing
- Project management
- Public policy/law/corporate compliance
- Quality assurance control
- Regulatory affairs
- Research and development
- Statistics
Learning objectives
- Describe the current and evolving regulatory environment in Canada
- Summarize current methods used in clinical trials, patient engagement, and improving market access
- Discuss approaches on international harmonization, work sharing, and implementation of current guidelines
- Review the various levels of transparency needed to maintain compliance in pre- and post-market activities
Program Committee
-
Marc Poitras, PhD, MBA • Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada -
Lisa Chartrand • Director, Regulatory Strategy and Policy
Hoffmann-La Roche Limited, Canada -
Loretta Del Bosco • Director, Regulatory Affairs Quality Assurance Operations
AbbVie Corporation, Canada -
Fiona M Frappier, PhD • Senior Policy Analyst
Health Canada, Canada -
Lorella Garofalo, PhD • Head of Regulatory Sciences
Pfizer Canada, Canada -
Melissa Hunt, MSc • Director
Health Canada, Canada -
Yatika Kohli, PhD, MBA • Executive Director - Global Regulatory Affairs
NoNO Inc, Canada -
Rania Mouchantaf, PhD • A/Executive Director
Health Canada, Canada -
Kristin Willemsen, MS • Vice President, Scientific & Regulatory Affairs
Food, Health & Consumer Products of Canada, Canada
Contact us
Registration Questions?
Check out our 2019 Program!
On Demand Content Preview Webinar
Key Factors for Success for Dossiers Relying on Third-Party Data (SRTD)
